• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

IDP:GR

212.280 EUR 0.680 0.32%

As of 13:53:09 ET on 04/17/2014.

Snapshot for Biogen Idec Inc (IDP)

Open: 206.700 Day's Range: 206.700 - 212.280 Volume: 140
Previous Close: 211.600 52wk Range: 148.087 - 258.500 1-Yr Rtn: +38.75%

Stock Chart for IDP

No chart data available.
  • IDP:GR 212.280
  • 1D
  • 1M
  • 1Y
211.600
Interactive IDP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IDP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.8900
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 11.3290
Est. PEG Ratio 1.3100
Market Cap (M EUR) 50,181.70
Shares Outstanding (M) 236.39
30 Day Average Volume 1,230
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IDP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IDP

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOStephen H Holtzman "Steve"Exec VP:Corporate Development
More Company Profile & Key Executives for IDP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil